Blood triacylglycerols: a lipidomic window on diet and disease
- 11 April 2016
- journal article
- review article
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 44 (2) , 638-644
Abstract
Although the measurement of triacylglycerols (TAGs) by clinical chemistry has been used in the diagnosis of a range of metabolic diseases, such approaches ignore the different species of TAGs that contribute to the total concentration. With the advent of LC and direct infusion forms of MS it is now possible to profile the individual TAGs in blood plasma or tissue extracts. This mini review surveys the information that is obtainable from the lipidomic profiling of TAGs in following metabolic diseases such as type 2 diabetes (T2DM), cardiovascular disease (CVD) and non-alcoholic fatty liver disease, as well as the development of insulin resistance and obesity.Keywords
This publication has 48 references indexed in Scilit:
- Inclusion of Plasma Lipid Species Improves Classification of Individuals at Risk of Type 2 DiabetesPLOS ONE, 2013
- Plasma lipid profiling in a large population-based cohortJournal of Lipid Research, 2013
- Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 DiabetesPLOS ONE, 2013
- Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine ModelPLOS ONE, 2011
- Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humansJournal of Clinical Investigation, 2011
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisJournal of Clinical Investigation, 2009
- Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty LiverDiabetes, 2009
- Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and WomenJAMA, 2007
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005